IMPLANT SITE URTICARIA

IMPLANT SITE URTICARIA was reported 98 times

IMPLANT SITE URTICARIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFAMELANOTIDE 2 0.0952
1 HISTRELIN ACETATE 6 0.0068
2 ETONOGESTREL 83 0.0014
3 OXCARBAZEPINE 2 0.0001
4 CARIPRAZINE 1 0.0001
5 ZONISAMIDE 1 0.0001
6 ERGOCALCIFEROL 2 0.0001
7 BREXPIPRAZOLE 1 0.0001
8 DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1 0.0000
9 SERTRALINE HYDROCHLORIDE 3 0.0000
10 DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE 1 0.0000
11 DIVALPROEX SODIUM 1 0.0000
12 ESCITALOPRAM 3 0.0000
13 TOPIRAMATE 1 0.0000
14 CLONIDINE 1 0.0000
15 MELATONIN 1 0.0000
16 DULOXETINE HYDROCHLORIDE 1 0.0000
17 VALACYCLOVIR HYDROCHLORIDE 1 0.0000
18 POLYETHYLENE GLYCOL 3350 1 0.0000
19 BUPROPION HYDROCHLORIDE 1 0.0000
20 LAMOTRIGINE 1 0.0000
21 LEVETIRACETAM 1 0.0000
22 HYDROCHLOROTHIAZIDE 1 0.0000
23 IBUPFROFEN 1 0.0000
24 IBUPROFEN TABLETS USP, 200MG 1 0.0000
25 IBUPROFEN ORAL 1 0.0000
26 IBUPROFEN CAPSULES 200 MG 1 0.0000
27 ALPRAZOLAM 1 0.0000
28 FOLIC ACID 1 0.0000
29 IBUPROFEN 1 0.0000
30 OMEPRAZOLE MAGNESIUM 1 0.0000
31 ADALIMUMAB 1 0.0000